A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. L-MTP-PE activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called MEPACT, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.